Ramucirumab Plus Pembrolizumab vs Usual Care for Treatment of Stage IV or Recurrent Non-Small Cell Lung Cancer Following Immunotherapy, Pragmatica-Lung Study
SWOG Cancer Research Network
SWOG Cancer Research Network
City of Hope Medical Center
SWOG Cancer Research Network
Pfizer
PrECOG, LLC.
Institut Paoli-Calmettes
Guangdong Provincial People's Hospital
Abramson Cancer Center at Penn Medicine
Fudan University
Fundación GECP